a source for capital and partners. In 2007, Leon Recanati and Gross, together with Cohen-Arazi, reviewed a series of Gross's ideas and chose 15 technologies on which to focus. Below follows a list of some of the early stage startup companies that Rainbow has established out of these 15 by segment. The products of these companies are all at the pre-clinical stage of development. As of December 2019, no submissions by these companies to the FDA have been made for device approvals. Cardiovascular: Enopace Biomedical, treatment for congestive heart failure; Vascular Dynamics, implantable stent for the treatment of hypertension. Diabetes: GluSense, continuous glucose biosensor for diabetes patients. Ophthalmology: PharmaLight, ocular drug delivery platform that administers therapeutics, including macro molecules, to the posterior segment of the eye; Bio Lens; Nano Retina, developing the Bio-Retina, a bionic retina designed to return full sight to those blinded by a degenerative condition. Aesthetic/Body Shaping: Slender Medical, body contouring and fat reduction system utilizing ultrasound. BPH: ProstaPlant Urology Systems, transurethral implant for symptomatic benign prostatic hyperplasia and lower urinary tract symptoms. Gynecology: Fibro Control, treatment for uterine fibroids. Dental/Maxillofacial: Maxillent, a solution for a fundamental problem in the field of dental implants. Memberships Gross is a member of the Israeli Life Science Association. References Bibliography External links The official website of Rainbow Medical The International Life Science Institute website 1947 births Living people Hungarian emigrants to Israel Hungarian Jews Israeli aerospace engineers Israeli chief executives Israeli company founders Israeli inventors Israeli investors Israeli financiers Israeli Jews Jewish engineers Private equity and venture capital investors Technology company founders Technion – Israel Institute of Technology alumni